Abstract
Laminin, one of the most widely expressed extracellular matrix proteins, exerts many important functions in multiple organs/systems and at various developmental stages. Although its critical roles in embryonic development have been demonstrated, laminin’s functions at later stages remain largely unknown, mainly due to its intrinsic complexity and lack of research tools (most laminin mutants are embryonic lethal). With the advance of genetic and molecular techniques, many new laminin mutants have been generated recently. These new mutants usually have a longer lifespan and show previously unidentified phenotypes. Not only do these studies suggest novel functions of laminin, but also they provide invaluable animal models that allow investigation of laminin’s functions at late stages. Here, I first briefly introduce the nomenclature, structure, and biochemistry of laminin in general. Next, all the loss-of-function mutants/models for each laminin chain are discussed and their phenotypes compared. I hope to provide a comprehensive review on laminin functions and its loss-of-function models, which could serve as a reference for future research in this understudied field.
Similar content being viewed by others
References
Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, Engel J, Engvall E, Hohenester E, Jones JC, Kleinman HK, Marinkovich MP, Martin GR, Mayer U, Meneguzzi G, Miner JH, Miyazaki K, Patarroyo M, Paulsson M, Quaranta V, Sanes JR, Sasaki T, Sekiguchi K, Sorokin LM, Talts JF, Tryggvason K, Uitto J, Virtanen I, von der Mark K, Wewer UM, Yamada Y, Yurchenco PD (2005) A simplified laminin nomenclature. Matrix Biol 24(5):326–332. doi:10.1016/j.matbio.2005.05.006
Aumailley M (2013) The laminin family. Cell Adhes Migration 7(1):48–55. doi:10.4161/cam.22826
Durbeej M (2010) Laminins. Cell Tissue Res 339(1):259–268. doi:10.1007/s00441-009-0838-2
Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, Martin GR, Meneguzzi G, Paulsson M, Sanes J et al (1994) A new nomenclature for the laminins. Matrix Biol 14(3):209–211
Ferrigno O, Virolle T, Galliano MF, Chauvin N, Ortonne JP, Meneguzzi G, Aberdam D (1997) Murine laminin alpha3A and alpha3B isoform chains are generated by usage of two promoters and alternative splicing. J Biol Chem 272(33):20502–20507
Sasaki T, Timpl R (1999) Laminins. In: Kries T, Vale R (eds) Guidebook to the extracellular matrix, anchor, and adhesion proteins. Oxford University Press, Oxford, pp 434–443
Maurer P, Engel J (1996) Structure of laminins and their chain assembly. In: Ekblom P, Timpl R (eds) The laminins. Harwood Academic Press, Amsterdam, pp 27–49
Miner JH, Yurchenco PD (2004) Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 20:255–284. doi:10.1146/annurev.cellbio.20.010403.094555
Morita A, Sugimoto E, Kitagawa Y (1985) Post-translational assembly and glycosylation of laminin subunits in parietal endoderm-like F9 cells. Biochem J 229(1):259–264
Champliaud MF, Virtanen I, Tiger CF, Korhonen M, Burgeson R, Gullberg D (2000) Posttranslational modifications and beta/gamma chain associations of human laminin alpha1 and laminin alpha5 chains: purification of laminin-3 from placenta. Exp Cell Res 259(2):326–335. doi:10.1006/excr.2000.4980
Tzu J, Marinkovich MP (2008) Bridging structure with function: structural, regulatory, and developmental role of laminins. Int J Biochem Cell Biol 40(2):199–214. doi:10.1016/j.biocel.2007.07.015
Schneider H, Muhle C, Pacho F (2007) Biological function of laminin-5 and pathogenic impact of its deficiency. Eur J Cell Biol 86(11–12):701–717. doi:10.1016/j.ejcb.2006.07.004
Yurchenco PD, Wadsworth WG (2004) Assembly and tissue functions of early embryonic laminins and netrins. Curr Opin Cell Biol 16(5):572–579. doi:10.1016/j.ceb.2004.07.013
Kohfeldt E, Sasaki T, Gohring W, Timpl R (1998) Nidogen-2: a new basement membrane protein with diverse binding properties. J Mol Biol 282(1):99–109. doi:10.1006/jmbi.1998.2004
Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, Mann K, Timpl R, Krieg T, Engel J et al (1991) Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J 10(11):3137–3146
Aumailley M, Battaglia C, Mayer U, Reinhardt D, Nischt R, Timpl R, Fox JW (1993) Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int 43(1):7–12
Salmivirta K, Talts JF, Olsson M, Sasaki T, Timpl R, Ekblom P (2002) Binding of mouse nidogen-2 to basement membrane components and cells and its expression in embryonic and adult tissues suggest complementary functions of the two nidogens. Exp Cell Res 279(2):188–201
Mayer U, Nischt R, Poschl E, Mann K, Fukuda K, Gerl M, Yamada Y, Timpl R (1993) A single EGF-like motif of laminin is responsible for high affinity nidogen binding. EMBO J 12(5):1879–1885
Poschl E, Fox JW, Block D, Mayer U, Timpl R (1994) Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin gamma 1 chain. EMBO J 13(16):3741–3747
Poschl E, Mayer U, Stetefeld J, Baumgartner R, Holak TA, Huber R, Timpl R (1996) Site-directed mutagenesis and structural interpretation of the nidogen binding site of the laminin gamma1 chain. EMBO J 15(19):5154–5159
Stetefeld J, Mayer U, Timpl R, Huber R (1996) Crystal structure of three consecutive laminin-type epidermal growth factor-like (LE) modules of laminin gamma1 chain harboring the nidogen binding site. J Mol Biol 257(3):644–657. doi:10.1006/jmbi.1996.0191
Timpl R, Brown JC (1996) Supramolecular assembly of basement membranes. BioEssays 18(2):123–132. doi:10.1002/bies.950180208
Mayer U, Kohfeldt E, Timpl R (1998) Structural and genetic analysis of laminin-nidogen interaction. Ann N Y Acad Sci 857:130–142
Yurchenco PD, Patton BL (2009) Developmental and pathogenic mechanisms of basement membrane assembly. Curr Pharm Des 15(12):1277–1294
Ekblom P, Ekblom M, Fecker L, Klein G, Zhang HY, Kadoya Y, Chu ML, Mayer U, Timpl R (1994) Role of mesenchymal nidogen for epithelial morphogenesis in vitro. Development 120(7):2003–2014
Kadoya Y, Salmivirta K, Talts JF, Kadoya K, Mayer U, Timpl R, Ekblom P (1997) Importance of nidogen binding to laminin gamma1 for branching epithelial morphogenesis of the submandibular gland. Development 124(3):683–691
Tunggal J, Wartenberg M, Paulsson M, Smyth N (2003) Expression of the nidogen-binding site of the laminin gamma1 chain disturbs basement membrane formation and maintenance in F9 embryoid bodies. J Cell Sci 116(Pt 5):803–812
Breitkreutz D, Mirancea N, Schmidt C, Beck R, Werner U, Stark HJ, Gerl M, Fusenig NE (2004) Inhibition of basement membrane formation by a nidogen-binding laminin gamma1-chain fragment in human skin-organotypic cocultures. J Cell Sci 117(Pt 12):2611–2622. doi:10.1242/jcs.01127
Willem M, Miosge N, Halfter W, Smyth N, Jannetti I, Burghart E, Timpl R, Mayer U (2002) Specific ablation of the nidogen-binding site in the laminin gamma1 chain interferes with kidney and lung development. Development 129(11):2711–2722
Mokkapati S, Fleger-Weckmann A, Bechtel M, Koch M, Breitkreutz D, Mayer U, Smyth N, Nischt R (2011) Basement membrane deposition of nidogen 1 but not nidogen 2 requires the nidogen binding module of the laminin gamma1 chain. J Biol Chem 286(3):1911–1918. doi:10.1074/jbc.M110.149864
Yue B (2014) Biology of the extracellular matrix: an overview. J Glaucoma 23(8 Suppl 1):S20–S23. doi:10.1097/IJG.0000000000000108
Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. doi:10.1101/cshperspect.a005058
Yurchenco PD, Smirnov S, Mathus T (2002) Analysis of basement membrane self-assembly and cellular interactions with native and recombinant glycoproteins. Methods Cell Biol 69:111–144
Colognato H, Yurchenco PD (2000) Form and function: the laminin family of heterotrimers. Dev Dyn 218(2):213–234. doi:10.1002/(SICI)1097-0177(200006)218:2<213:AID-DVDY1>3.0.CO;2-R
Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM (2005) Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 85(3):979–1000. doi:10.1152/physrev.00014.2004
Ekblom P, Lonai P, Talts JF (2003) Expression and biological role of laminin-1. Matrix Biol 22(1):35–47
Miner JH, Cunningham J, Sanes JR (1998) Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain. J Cell Biol 143(6):1713–1723
Sasaki T, Fassler R, Hohenester E (2004) Laminin: the crux of basement membrane assembly. J Cell Biol 164(7):959–963. doi:10.1083/jcb.200401058
Miner JH (2008) Laminins and their roles in mammals. Microsc Res Tech 71(5):349–356. doi:10.1002/jemt.20563
Samuel MA, Valdez G, Tapia JC, Lichtman JW, Sanes JR (2012) Agrin and synaptic laminin are required to maintain adult neuromuscular junctions. PLoS ONE 7(10):e46663. doi:10.1371/journal.pone.0046663
Patton BL (2000) Laminins of the neuromuscular system. Microsc Res Tech 51(3):247–261. doi:10.1002/1097-0029(20001101)51:3<247:AID-JEMT5>3.0.CO;2-Z
Miner JH, Li C, Mudd JL, Go G, Sutherland AE (2004) Compositional and structural requirements for laminin and basement membranes during mouse embryo implantation and gastrulation. Development 131(10):2247–2256. doi:10.1242/dev.01112
Yin Y, Kikkawa Y, Mudd JL, Skarnes WC, Sanes JR, Miner JH (2003) Expression of laminin chains by central neurons: analysis with gene and protein trapping techniques. Genesis 36(2):114–127. doi:10.1002/gene.10206
Virtanen I, Gullberg D, Rissanen J, Kivilaakso E, Kiviluoto T, Laitinen LA, Lehto VP, Ekblom P (2000) Laminin alpha1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues. Exp Cell Res 257(2):298–309. doi:10.1006/excr.2000.4883
Lentz SI, Miner JH, Sanes JR, Snider WD (1997) Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons. J Comp Neurol 378(4):547–561
Thomas T, Dziadek M (1993) Genes coding for basement membrane glycoproteins laminin, nidogen, and collagen IV are differentially expressed in the nervous system and by epithelial, endothelial, and mesenchymal cells of the mouse embryo. Exp Cell Res 208(1):54–67. doi:10.1006/excr.1993.1222
Ekblom M, Klein G, Mugrauer G, Fecker L, Deutzmann R, Timpl R, Ekblom P (1990) Transient and locally restricted expression of laminin A chain mRNA by developing epithelial cells during kidney organogenesis. Cell 60(2):337–346
Alpy F, Jivkov I, Sorokin L, Klein A, Arnold C, Huss Y, Kedinger M, Simon-Assmann P, Lefebvre O (2005) Generation of a conditionally null allele of the laminin alpha1 gene. Genesis 43(2):59–70. doi:10.1002/gene.20154
Scheele S, Falk M, Franzen A, Ellin F, Ferletta M, Lonai P, Andersson B, Timpl R, Forsberg E, Ekblom P (2005) Laminin alpha1 globular domains 4-5 induce fetal development but are not vital for embryonic basement membrane assembly. Proc Natl Acad Sci USA 102(5):1502–1506. doi:10.1073/pnas.0405095102
Edwards MM, Mammadova-Bach E, Alpy F, Klein A, Hicks WL, Roux M, Simon-Assmann P, Smith RS, Orend G, Wu J, Peachey NS, Naggert JK, Lefebvre O, Nishina PM (2010) Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formation. J Biol Chem 285(10):7697–7711. doi:10.1074/jbc.M109.069575
Edwards MM, McLeod DS, Grebe R, Heng C, Lefebvre O, Lutty GA (2011) Lama1 mutations lead to vitreoretinal blood vessel formation, persistence of fetal vasculature, and epiretinal membrane formation in mice. BMC Dev Biol 11:60. doi:10.1186/1471-213X-11-60
Ichikawa-Tomikawa N, Ogawa J, Douet V, Xu Z, Kamikubo Y, Sakurai T, Kohsaka S, Chiba H, Hattori N, Yamada Y, Arikawa-Hirasawa E (2012) Laminin alpha1 is essential for mouse cerebellar development. Matrix Biol 31(1):17–28. doi:10.1016/j.matbio.2011.09.002
Zinkevich NS, Bosenko DV, Link BA, Semina EV (2006) laminin alpha 1 gene is essential for normal lens development in zebrafish. BMC Dev Biol 6:13. doi:10.1186/1471-213X-6-13
Karlstrom RO, Trowe T, Klostermann S, Baier H, Brand M, Crawford AD, Grunewald B, Haffter P, Hoffmann H, Meyer SU, Muller BK, Richter S, van Eeden FJ, Nusslein-Volhard C, Bonhoeffer F (1996) Zebrafish mutations affecting retinotectal axon pathfinding. Development 123:427–438
Paulus JD, Halloran MC (2006) Zebrafish bashful/laminin-alpha 1 mutants exhibit multiple axon guidance defects. Dev Dyn 235(1):213–224. doi:10.1002/dvdy.20604
Biehlmaier O, Makhankov Y, Neuhauss SC (2007) Impaired retinal differentiation and maintenance in zebrafish laminin mutants. Invest Ophthalmol Vis Sci 48(6):2887–2894. doi:10.1167/iovs.06-1212
Semina EV, Bosenko DV, Zinkevich NC, Soules KA, Hyde DR, Vihtelic TS, Willer GB, Gregg RG, Link BA (2006) Mutations in laminin alpha 1 result in complex, lens-independent ocular phenotypes in zebrafish. Dev Biol 299(1):63–77. doi:10.1016/j.ydbio.2006.07.005
Pathania M, Semina EV, Duncan MK (2014) Lens extrusion from Laminin alpha 1 mutant zebrafish. Sci World J 2014:524929. doi:10.1155/2014/524929
Xu H, Christmas P, Wu XR, Wewer UM, Engvall E (1994) Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA 91(12):5572–5576
Xu H, Wu XR, Wewer UM, Engvall E (1994) Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat Genet 8(3):297–302. doi:10.1038/ng1194-297
Tome FM, Evangelista T, Leclerc A, Sunada Y, Manole E, Estournet B, Barois A, Campbell KP, Fardeau M (1994) Congenital muscular dystrophy with merosin deficiency. C R Acad Sci 317(4):351–357
Michelson AM, Russell ES, Harman PJ (1955) Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc Natl Acad Sci USA 41(12):1079–1084
Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP (1994) Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem 269(19):13729–13732
Kuang W, Xu H, Vachon PH, Liu L, Loechel F, Wewer UM, Engvall E (1998) Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J Clin Invest 102(4):844–852. doi:10.1172/JCI3705
Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima Y, Arahata K, Nabeshima Y, Takeda S (1997) Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 415(1):33–39
Nakagawa M, Miyagoe-Suzuki Y, Ikezoe K, Miyata Y, Nonaka I, Harii K, Takeda S (2001) Schwann cell myelination occurred without basal lamina formation in laminin alpha2 chain-null mutant (dy3K/dy3K) mice. Glia 35(2):101–110
Menezes MJ, McClenahan FK, Leiton CV, Aranmolate A, Shan X, Colognato H (2014) The extracellular matrix protein laminin alpha2 regulates the maturation and function of the blood–brain barrier. J Neurosci 34(46):15260–15280. doi:10.1523/JNEUROSCI.3678-13.2014
Sunada Y, Edgar TS, Lotz BP, Rust RS, Campbell KP (1995) Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 45(11):2084–2089
Gawlik K, Miyagoe-Suzuki Y, Ekblom P, Takeda S, Durbeej M (2004) Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice. Hum Mol Genet 13(16):1775–1784. doi:10.1093/hmg/ddh190
Hager M, Gawlik K, Nystrom A, Sasaki T, Durbeej M (2005) Laminin {alpha}1 chain corrects male infertility caused by absence of laminin {alpha}2 chain. Am J Pathol 167(3):823–833
Gawlik KI, Mayer U, Blomberg K, Sonnenberg A, Ekblom P, Durbeej M (2006) Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan. FEBS Lett 580(7):1759–1765. doi:10.1016/j.febslet.2006.02.027
Gawlik KI, Durbeej M (2010) Transgenic overexpression of laminin alpha1 chain in laminin alpha2 chain-deficient mice rescues the disease throughout the lifespan. Muscle Nerve 42(1):30–37. doi:10.1002/mus.21616
Gawlik KI, Li JY, Petersen A, Durbeej M (2006) Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy. Hum Mol Genet 15(18):2690–2700. doi:10.1093/hmg/ddl201
Gawlik KI, Akerlund M, Carmignac V, Elamaa H, Durbeej M (2010) Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency. PLoS ONE 5(7):e11549. doi:10.1371/journal.pone.0011549
Rooney JE, Knapp JR, Hodges BL, Wuebbles RD, Burkin DJ (2012) Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy. Am J Pathol 180(4):1593–1602. doi:10.1016/j.ajpath.2011.12.019
Van Ry PM, Minogue P, Hodges BL, Burkin DJ (2014) Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy. Hum Mol Genet 23(2):383–396. doi:10.1093/hmg/ddt428
Goudenege S, Lamarre Y, Dumont N, Rousseau J, Frenette J, Skuk D, Tremblay JP (2010) Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Mol Therapy 18(12):2155–2163. doi:10.1038/mt.2010.165
Rooney JE, Gurpur PB, Burkin DJ (2009) Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci USA 106(19):7991–7996. doi:10.1073/pnas.0811599106
Yao Y, Norris EH, Widdowson EM, Strickland S (2016) Laminin regulates PDGFRbeta cell stemness and muscle development. Nat Commun 7:11415. doi:10.1038/ncomms11415
Moll J, Barzaghi P, Lin S, Bezakova G, Lochmuller H, Engvall E, Muller U, Ruegg MA (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 413(6853):302–307. doi:10.1038/35095054
Bentzinger CF, Barzaghi P, Lin S, Ruegg MA (2005) Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. FASEB J 19(8):934–942. doi:10.1096/fj.04-3376com
Meinen S, Barzaghi P, Lin S, Lochmuller H, Ruegg MA (2007) Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages. J Cell Biol 176(7):979–993. doi:10.1083/jcb.200611152
Qiao C, Li J, Zhu T, Draviam R, Watkins S, Ye X, Chen C, Li J, Xiao X (2005) Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin. Proc Natl Acad Sci USA 102(34):11999–12004. doi:10.1073/pnas.0502137102
Girgenrath M, Dominov JA, Kostek CA, Miller JB (2004) Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J Clin Investig 114(11):1635–1639. doi:10.1172/JCI22928
Girgenrath M, Beermann ML, Vishnudas VK, Homma S, Miller JB (2009) Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Ann Neurol 65(1):47–56. doi:10.1002/ana.21523
Erb M, Meinen S, Barzaghi P, Sumanovski LT, Courdier-Fruh I, Ruegg MA, Meier T (2009) Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency. J Pharmacol Exp Ther 331(3):787–795. doi:10.1124/jpet.109.160754
Carmignac V, Quere R, Durbeej M (2011) Proteasome inhibition improves the muscle of laminin alpha2 chain-deficient mice. Hum Mol Genet 20(3):541–552. doi:10.1093/hmg/ddq499
Korner Z, Fontes-Oliveira CC, Holmberg J, Carmignac V, Durbeej M (2014) Bortezomib partially improves laminin alpha2 chain-deficient muscular dystrophy. Am J Pathol 184(5):1518–1528. doi:10.1016/j.ajpath.2014.01.019
Carmignac V, Svensson M, Korner Z, Elowsson L, Matsumura C, Gawlik KI, Allamand V, Durbeej M (2011) Autophagy is increased in laminin alpha2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A. Hum Mol Genet 20(24):4891–4902. doi:10.1093/hmg/ddr427
Meinen S, Lin S, Ruegg MA (2012) Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-alpha2-deficient congenital muscular dystrophy (MDC1A). Skelet Muscle 2(1):18. doi:10.1186/2044-5040-2-18
Meinen S, Lin S, Thurnherr R, Erb M, Meier T, Ruegg MA (2011) Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice. EMBO Mol Med 3(8):465–479. doi:10.1002/emmm.201100151
Yamauchi J, Kumar A, Duarte L, Mehuron T, Girgenrath M (2013) Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A. Hum Mol Genet 22(21):4306–4317. doi:10.1093/hmg/ddt280
Durbeej M (2015) Laminin-alpha2 chain-deficient congenital muscular dystrophy: pathophysiology and development of treatment. Curr Top Membr 76:31–60. doi:10.1016/bs.ctm.2015.05.002
Carter WG, Ryan MC, Gahr PJ (1991) Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell 65(4):599–610
Aberdam D, Galliano MF, Vailly J, Pulkkinen L, Bonifas J, Christiano AM, Tryggvason K, Uitto J, Epstein EH Jr, Ortonne JP et al (1994) Herlitz’s junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet 6(3):299–304. doi:10.1038/ng0394-299
Ryan MC, Lee K, Miyashita Y, Carter WG (1999) Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 145(6):1309–1323
McGrath JA, Kivirikko S, Ciatti S, Moss C, Dunnill GS, Eady RA, Rodeck CH, Christiano AM, Uitto J (1995) A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in Herlitz junctional epidermolysis bullosa: prenatal exclusion in a fetus at risk. Genomics 29(1):282–284
Urich D, Eisenberg JL, Hamill KJ, Takawira D, Chiarella SE, Soberanes S, Gonzalez A, Koentgen F, Manghi T, Hopkinson SB, Misharin AV, Perlman H, Mutlu GM, Budinger GR, Jones JC (2011) Lung-specific loss of the laminin alpha3 subunit confers resistance to mechanical injury. J Cell Sci 124(Pt 17):2927–2937. doi:10.1242/jcs.080911
Frieser M, Nockel H, Pausch F, Roder C, Hahn A, Deutzmann R, Sorokin LM (1997) Cloning of the mouse laminin alpha 4 cDNA. Expression in a subset of endothelium. Eur J Biochem/FEBS 246 (3):727–735
Iivanainen A, Kortesmaa J, Sahlberg C, Morita T, Bergmann U, Thesleff I, Tryggvason K (1997) Primary structure, developmental expression, and immunolocalization of the murine laminin alpha4 chain. J Biol Chem 272(44):27862–27868
Lefebvre O, Sorokin L, Kedinger M, Simon-Assmann P (1999) Developmental expression and cellular origin of the laminin alpha2, alpha4, and alpha5 chains in the intestine. Dev Biol 210(1):135–150. doi:10.1006/dbio.1999.9270
Patton BL, Miner JH, Chiu AY, Sanes JR (1997) Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol 139(6):1507–1521
Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A, Sorokin L, Risling M, Cao Y, Tryggvason K (2002) Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol 22(4):1194–1202
Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nilsson P, Robenek H, Tryggvason K, Song J, Korpos E, Loser K, Beissert S, Georges-Labouesse E, Sorokin LM (2009) Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med 15(5):519–527. doi:10.1038/nm.1957
Patton BL, Cunningham JM, Thyboll J, Kortesmaa J, Westerblad H, Edstrom L, Tryggvason K, Sanes JR (2001) Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. Nat Neurosci 4(6):597–604. doi:10.1038/88414
Abrass CK, Hansen KM, Patton BL (2010) Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor. Am J Pathol 176(2):839–849. doi:10.2353/ajpath.2010.090570
Vaicik MK, Thyboll Kortesmaa J, Moverare-Skrtic S, Kortesmaa J, Soininen R, Bergstrom G, Ohlsson C, Chong LY, Rozell B, Emont M, Cohen RN, Brey EM, Tryggvason K (2014) Laminin alpha4 deficient mice exhibit decreased capacity for adipose tissue expansion and weight gain. PLoS ONE 9(10):e109854. doi:10.1371/journal.pone.0109854
Yang D, Bierman J, Tarumi YS, Zhong YP, Rangwala R, Proctor TM, Miyagoe-Suzuki Y, Takeda S, Miner JH, Sherman LS, Gold BG, Patton BL (2005) Coordinate control of axon defasciculation and myelination by laminin-2 and -8. J Cell Biol 168(4):655–666. doi:10.1083/jcb.200411158
Miner JH, Li C, Patton BL (2004) Laminins alpha2 and alpha4 in pancreatic acinar basement membranes are required for basal receptor localization. J Histochem Cytochem 52(2):153–156
Coles EG, Gammill LS, Miner JH, Bronner-Fraser M (2006) Abnormalities in neural crest cell migration in laminin alpha5 mutant mice. Dev Biol 289(1):218–228. doi:10.1016/j.ydbio.2005.10.031
Miner JH, Li C (2000) Defective glomerulogenesis in the absence of laminin alpha5 demonstrates a developmental role for the kidney glomerular basement membrane. Dev Biol 217(2):278–289. doi:10.1006/dbio.1999.9546
Nguyen NM, Miner JH, Pierce RA, Senior RM (2002) Laminin alpha 5 is required for lobar septation and visceral pleural basement membrane formation in the developing mouse lung. Dev Biol 246(2):231–244. doi:10.1006/dbio.2002.0658
Gao J, DeRouen MC, Chen CH, Nguyen M, Nguyen NT, Ido H, Harada K, Sekiguchi K, Morgan BA, Miner JH, Oro AE, Marinkovich MP (2008) Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis. Genes Dev 22(15):2111–2124. doi:10.1101/gad.1689908
Li J, Tzu J, Chen Y, Zhang YP, Nguyen NT, Gao J, Bradley M, Keene DR, Oro AE, Miner JH, Marinkovich MP (2003) Laminin-10 is crucial for hair morphogenesis. EMBO J 22(10):2400–2410. doi:10.1093/emboj/cdg239
Mahoney ZX, Stappenbeck TS, Miner JH (2008) Laminin alpha 5 influences the architecture of the mouse small intestine mucosa. J Cell Sci 121(Pt 15):2493–2502. doi:10.1242/jcs.025528
Ritie L, Spenle C, Lacroute J, Bolcato-Bellemin AL, Lefebvre O, Bole-Feysot C, Jost B, Klein A, Arnold C, Kedinger M, Bagnard D, Orend G, Simon-Assmann P (2012) Abnormal Wnt and PI3Kinase signaling in the malformed intestine of lama5 deficient mice. PLoS ONE 7(5):e37710. doi:10.1371/journal.pone.0037710
Bolcato-Bellemin AL, Lefebvre O, Arnold C, Sorokin L, Miner JH, Kedinger M, Simon-Assmann P (2003) Laminin alpha5 chain is required for intestinal smooth muscle development. Dev Biol 260(2):376–390
Kikkawa Y, Miner JH (2006) Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function. Dev Biol 296(1):265–277. doi:10.1016/j.ydbio.2006.04.463
Nishimune H, Valdez G, Jarad G, Moulson CL, Muller U, Miner JH, Sanes JR (2008) Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction. J Cell Biol 182(6):1201–1215. doi:10.1083/jcb.200805095
Shannon MB, Patton BL, Harvey SJ, Miner JH (2006) A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease. J Am Soc Nephrol JASN 17(7):1913–1922. doi:10.1681/ASN.2005121298
Goldberg S, Adair-Kirk TL, Senior RM, Miner JH (2010) Maintenance of glomerular filtration barrier integrity requires laminin alpha5. J Am Soc Nephrol JASN 21(4):579–586. doi:10.1681/ASN.2009091004
Fukumoto S, Miner JH, Ida H, Fukumoto E, Yuasa K, Miyazaki H, Hoffman MP, Yamada Y (2006) Laminin alpha5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. J Biol Chem 281(8):5008–5016. doi:10.1074/jbc.M509295200
Rebustini IT, Patel VN, Stewart JS, Layvey A, Georges-Labouesse E, Miner JH, Hoffman MP (2007) Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling. Dev Biol 308(1):15–29. doi:10.1016/j.ydbio.2007.04.031
Nguyen NM, Kelley DG, Schlueter JA, Meyer MJ, Senior RM, Miner JH (2005) Epithelial laminin alpha5 is necessary for distal epithelial cell maturation, VEGF production, and alveolization in the developing murine lung. Dev Biol 282(1):111–125. doi:10.1016/j.ydbio.2005.02.031
Liu YB, Tewari A, Salameh J, Arystarkhova E, Hampton TG, Brashear A, Ozelius LJ, Khodakhah K, Sweadner KJ (2015) A dystonia-like movement disorder with brain and spinal neuronal defects is caused by mutation of the mouse laminin beta1 subunit, Lamb1. eLife 4. doi:10.7554/eLife.11102
Noakes PG, Gautam M, Mudd J, Sanes JR, Merlie JP (1995) Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin beta 2. Nature 374(6519):258–262. doi:10.1038/374258a0
Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR, Merlie JP (1995) The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat Genet 10(4):400–406. doi:10.1038/ng0895-400
Miner JH, Go G, Cunningham J, Patton BL, Jarad G (2006) Transgenic isolation of skeletal muscle and kidney defects in laminin beta2 mutant mice: implications for Pierson syndrome. Development 133(5):967–975. doi:10.1242/dev.02270
Jarad G, Cunningham J, Shaw AS, Miner JH (2006) Proteinuria precedes podocyte abnormalities inLamb2−/− mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Investig 116(8):2272–2279. doi:10.1172/JCI28414
Libby RT, Lavallee CR, Balkema GW, Brunken WJ, Hunter DD (1999) Disruption of laminin beta2 chain production causes alterations in morphology and function in the CNS. J Neurosci 19(21):9399–9411
Denes V, Witkovsky P, Koch M, Hunter DD, Pinzon-Duarte G, Brunken WJ (2007) Laminin deficits induce alterations in the development of dopaminergic neurons in the mouse retina. Vis Neurosci 24(4):549–562. doi:10.1017/S0952523807070514
Zenker M, Tralau T, Lennert T, Pitz S, Mark K, Madlon H, Dotsch J, Reis A, Muntefering H, Neumann LM (2004) Congenital nephrosis, mesangial sclerosis, and distinct eye abnormalities with microcoria: an autosomal recessive syndrome. Am J Med Genet Part A 130A(2):138–145. doi:10.1002/ajmg.a.30310
Zenker M, Pierson M, Jonveaux P, Reis A (2005) Demonstration of two novel LAMB2 mutations in the original Pierson syndrome family reported 42 years ago. Am J Med Genet Part A 138(1):73–74. doi:10.1002/ajmg.a.30894
Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R, Pitz S, Schumacher V, Royer-Pokora B, Wuhl E, Cochat P, Bouvier R, Kraus C, Mark K, Madlon H, Dotsch J, Rascher W, Maruniak-Chudek I, Lennert T, Neumann LM, Reis A (2004) Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 13(21):2625–2632. doi:10.1093/hmg/ddh284
Kuster JE, Guarnieri MH, Ault JG, Flaherty L, Swiatek PJ (1997) IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. Mamm Genome 8(9):673–681
Muhle C, Neuner A, Park J, Pacho F, Jiang Q, Waddington SN, Schneider H (2006) Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease. Gene Ther 13(23):1665–1676. doi:10.1038/sj.gt.3302832
Hammersen J, Hou J, Wunsche S, Brenner S, Winkler T, Schneider H (2015) A new mouse model of junctional epidermolysis bullosa: the LAMB3 628G>A knockin mouse. J Invest Dermatol 135(3):921–924. doi:10.1038/jid.2014.466
Smith CG, Naven M, Harris R, Colley J, West H, Li N, Liu Y, Adams R, Maughan TS, Nichols L, Kaplan R, Wagner MJ, McLeod HL, Cheadle JP (2013) Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer. Hum Mutat 34(7):1026–1034. doi:10.1002/humu.22333
Choi MR, An CH, Yoo NJ, Lee SH (2015) Laminin gene LAMB4 is somatically mutated and expressionally altered in gastric and colorectal cancers. APMIS 123(1):65–71. doi:10.1111/apm.12309
Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkins NA, Copeland NG, Sanes JR (1997) The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8–11, and cloning of a novel alpha3 isoform. J Cell Biol 137(3):685–701
Smyth N, Vatansever HS, Meyer M, Frie C, Paulsson M, Edgar D (1998) The targeted deletion of the LAMC1 gene. Ann N Y Acad Sci 857:283–286
Smyth N, Vatansever HS, Murray P, Meyer M, Frie C, Paulsson M, Edgar D (1999) Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation. J Cell Biol 144(1):151–160
Murray P, Edgar D (2000) Regulation of programmed cell death by basement membranes in embryonic development. J Cell Biol 150(5):1215–1221
Chen ZL, Strickland S (2003) Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol 163(4):889–899. doi:10.1083/jcb.200307068
Chen ZL, Haegeli V, Yu H, Strickland S (2009) Cortical deficiency of laminin gamma1 impairs the AKT/GSK-3beta signaling pathway and leads to defects in neurite outgrowth and neuronal migration. Dev Biol 327(1):158–168. doi:10.1016/j.ydbio.2008.12.006
Yu WM, Feltri ML, Wrabetz L, Strickland S, Chen ZL (2005) Schwann cell-specific ablation of laminin gamma1 causes apoptosis and prevents proliferation. J Neurosci 25(18):4463–4472. doi:10.1523/JNEUROSCI.5032-04.2005
Yang DH, McKee KK, Chen ZL, Mernaugh G, Strickland S, Zent R, Yurchenco PD (2011) Renal collecting system growth and function depend upon embryonic gamma1 laminin expression. Development 138(20):4535–4544. doi:10.1242/dev.071266
Chen ZL, Yao Y, Norris EH, Kruyer A, Jno-Charles O, Akhmerov A, Strickland S (2013) Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke. J Cell Biol 202(2):381–395. doi:10.1083/jcb.201212032
Yao Y, Chen ZL, Norris EH, Strickland S (2014) Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun 5:3413. doi:10.1038/ncomms4413
Yao Y, Norris EH, Strickland S (2015) The cellular origin of laminin determines its role in blood pressure regulation. Cell Mol Life Sci 72(5):999–1008. doi:10.1007/s00018-014-1732-y
Pulkkinen L, Christiano AM, Airenne T, Haakana H, Tryggvason K, Uitto J (1994) Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet 6(3):293–297. doi:10.1038/ng0394-293
Meng X, Klement JF, Leperi DA, Birk DE, Sasaki T, Timpl R, Uitto J, Pulkkinen L (2003) Targeted inactivation of murine laminin gamma2-chain gene recapitulates human junctional epidermolysis bullosa. J Invest Dermatol 121(4):720–731. doi:10.1046/j.1523-1747.2003.12515.x
Nguyen NM, Pulkkinen L, Schlueter JA, Meneguzzi G, Uitto J, Senior RM (2006) Lung development in laminin gamma2 deficiency: abnormal tracheal hemidesmosomes with normal branching morphogenesis and epithelial differentiation. Respir Res 7:28. doi:10.1186/1465-9921-7-28
Adair-Kirk TL, Griffin GL, Meyer MJ, Kelley DG, Miner JH, Keene DR, Marinkovich MP, Ruppert JM, Uitto J, Senior RM (2012) Keratinocyte-targeted expression of human laminin gamma2 rescues skin blistering and early lethality of laminin gamma2 deficient mice. PLoS ONE 7(9):e45546. doi:10.1371/journal.pone.0045546
Li YN, Radner S, French MM, Pinzon-Duarte G, Daly GH, Burgeson RE, Koch M, Brunken WJ (2012) The gamma3 chain of laminin is widely but differentially expressed in murine basement membranes: expression and functional studies. Matrix Biol 31(2):120–134. doi:10.1016/j.matbio.2011.12.002
Radner S, Banos C, Bachay G, Li YN, Hunter DD, Brunken WJ, Yee KT (2013) beta2 and gamma3 laminins are critical cortical basement membrane components: ablation of Lamb2 and Lamc3 genes disrupts cortical lamination and produces dysplasia. Dev Neurobiol 73(3):209–229. doi:10.1002/dneu.22057
Pinzon-Duarte G, Daly G, Li YN, Koch M, Brunken WJ (2010) Defective formation of the inner limiting membrane in laminin beta2- and gamma3-null mice produces retinal dysplasia. Invest Ophthalmol Vis Sci 51(3):1773–1782. doi:10.1167/iovs.09-4645
Hirrlinger PG, Pannicke T, Winkler U, Claudepierre T, Varshney S, Schulze C, Reichenbach A, Brunken WJ, Hirrlinger J (2011) Genetic deletion of laminin isoforms beta2 and gamma3 induces a reduction in Kir4.1 and aquaporin-4 expression and function in the retina. PLoS ONE 6(1):e16106. doi:10.1371/journal.pone.0016106
Gnanaguru G, Bachay G, Biswas S, Pinzon-Duarte G, Hunter DD, Brunken WJ (2013) Laminins containing the beta2 and gamma3 chains regulate astrocyte migration and angiogenesis in the retina. Development 140(9):2050–2060. doi:10.1242/dev.087817
Acknowledgments
This work was supported by Myotonic Dystrophy Foundation Fund-A-Fellow Grant (Y.Y.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Yao, Y. Laminin: loss-of-function studies. Cell. Mol. Life Sci. 74, 1095–1115 (2017). https://doi.org/10.1007/s00018-016-2381-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-016-2381-0